BTG is a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible; supporting clinicians, healthcare systems and governments while offering hope to patients and their families.  

As a fully integrated company, we have the experience and capabilities to acquire, develop, and manufacture our medicines to the highest standards, and make them available worldwide through our secure supply chain.

Improving patients’ quality of life and offering hope is what motivates and inspires us.

BTG was acquired by SERB Pharmaceuticals in 2020. SERB now operates in the US as BTG Pharmaceuticals. 

Health Care

BTG Pharmaceuticals

Anthony Higham

Sam Elcomb

Thomas Kolaras

Antoine Bernasconi

Vincent Sainte - Catherine

Marie Botin

Christon Hill

Bich Pham - Huy

Ben Watt

Arthur Pignot

The Executive Team at BTG Pharmaceuticals is responsible for steering the company's strategic direction, operational efficiency, and commercial success across various regions. This team oversees the development and execution of business strategies, drives innovation in product development, manages financial health, and ensures the effective commercialization of BTG’s pharmaceutical solutions to improve patient outcomes globally.

Executive Team

Leadership Team

Commercial Strategy Team

Business Strategy and Analysis

Executive Team

About

Team members

Other teams at BTG Pharmaceuticals

Leadership Team

Commercial Strategy Team

Business Strategy and Analysis